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ABSTRACT
We describe gene targeting experiments involving a
human cell line (RAN10) containing, in addition to
its endogenous alleles, two ectopic alleles of the
interferon-inducible gene 6-16. The frequency of
gene targeting at one of the ectopic 6-16 alleles
(H3.7) was 34-fold greater than the combined fre-
quency of gene targeting involving endogenous
6-16 alleles in RAN10. Preference for H3.7 was main-
tained when the target loci in RAN10 were transcrip-
tionally activated by interferon. Despite the 34-fold
preference for H3.7, the absolute gene targeting ef®-
ciency in RAN10 was only 3-fold higher than in the
parental HT1080 cell line. These data suggest that
different alleles can compete with each other, and
perhaps with non-homologous loci, in a step which
is necessary, but not normally rate-limiting, for gene
targeting. The ef®ciency of this step can therefore
be more sensitive to chromosomal position effects
than the rate-determining steps for gene targeting.
The nature of the position effects involved remains
unknown but does not correlate with transcription
status, which in our system has a very modest
in¯uence on the frequency of gene targeting. In
summary, our work unequivocally identi®es a
position effect on gene targeting in human cells.
INTRODUCTION
The relationship between the function of a segment of
genomic DNA and its chromosomal position is an important
focus of attention in molecular genetics. Most often this has
been investigated by observing how gene expression is
affected by changes in its chromosomal position or sequence
context (1), but there are other aspects of DNA function,
including recombination, whose sensitivity to chromosomal
position may be informative. It is therefore interesting to know
how gene targeting, a biologically and technically important
form of DNA recombination in mitotic mammalian cells, is
in¯uenced by chromosomal position.
Gene targeting is the introduction of de®ned changes into
the genome via homologous recombination (HR) between a
chromosomal target locus and a transfected DNA molecule
(2,3). HR is an important DNA repair pathway in mammalian
cells (4,5), but it must be tightly regulated to avoid harmful
chromosomal rearrangements, and gene targeting is generally
very inef®cient. Improvements in the ef®ciency of gene
targeting would greatly aid its use as a tool in somatic cell
genetics (6,7) and as a potential route to therapeutic gene
repair (8). For these reasons, and also to improve our
understanding of mitotic HR, a better de®nition of the factors
that in¯uence gene targeting ef®ciencies is desirable.
Gene targeting frequencies are very variable, for reasons
that are not always clear. There are many variables known or
suspected to in¯uence gene targeting frequencies and path-
ways (8,9), including the amount (10,11) and quality (12,13)
of the region of homology, the nature and positioning of
selectable markers (14±17) and the method by which the
targeting construct is delivered to cells (9,18±20). Never-
theless, even targeting vectors that have been similarly
designed and delivered to the same cell type can have very
different targeting frequencies, leading to the idea that the
nature of the target locus is important.
It is likely that speci®c sequences in the target locus, either
within or close to the region of homology with the targeting
vector, promote HR. Sequence `hotspots' that promote
recombination have been studied in systems from bacteria,
yeast and man (21). In eukaryotes, most attention has been
paid to meiotic recombination hotspots (22). Evidence for
mitotic recombination hotspots in yeast (23) and human cells
(24,25) has also been reported, however. Microsatellite
(26,27) and minisatellite (28) sequences have been shown to
promote HR between extrachromosomal substrates in mam-
malian cells. Direct evidence for an effect of such sequences
on gene targeting itself, however, is still lacking (29).
It is also possible that aspects of chromatin structure at the
target locus that cannot be predicted from nucleotide sequence
correlate with gene targeting frequencies, just as aspects of
chromatin structure, re¯ected in the degree of histone
acetylation, DNase hypersensitivity and DNA demethylation,
are known to be associated with expressed genes (30,31).
While there is evidence that transcription can stimulate
intrachromosomal HR (32), extrachromosomal HR (33) and
gene targeting (34), it is also known that untranscribed genes
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can be disrupted by gene targeting with appreciable ef®-
ciencies (35). Meanwhile, the relationship, if any, between
chromatin structure and gene targeting ef®ciencies remains to
be explored.
Prior to conducting such analyses it is of interest to establish
unequivocally the importance of chromosomal location in
gene targeting. To do this it is necessary to vary the
chromosomal location of the target locus whilst holding
constant the nucleotide sequence of the target. In yeast, the
effect of chromosomal position on interallelic recombination
(36) or gene targeting (37) was remarkably small. In many
respects, however, including its high ef®ciency and sensitivity
to target copy number (38,39), gene targeting in yeast is very
different to that in mammalian cells. To our knowledge the
only studies of this kind involving mammalian cells were by
Lin et al. (40) and Thomas et al. (41), both in mouse L cells.
While suggestive of a strong chromosomal position effect, the
former study was complicated by the use of carrier DNA and
the calcium phosphate delivery method. The latter study did
not report major variations in targeting frequencies, but only
three cell lines were compared, and where a cell line contained
multiple copies of target genes, potential frequency variations
between copies were not investigated.
To re-investigate this problem we chose as our target the
human interferon (IFN)-inducible gene 6-16 (42), which has
several attractions in this context. First, the 6-16 gene is
small, making it relatively easy to introduce additional alleles
at ectopic chromosomal sites. Secondly, in contrast to
commonly used model target genes, such as that encoding
neomycin phosphotransferase (neo), endogenous target alleles
exist and these can serve as internal reference targets.
Furthermore, the ability of mammalian cells to recognise
and modify foreign DNA (43,44) is less of a complication for
6-16 gene targeting. Thirdly, because the 6-16 gene is
transcriptionally inducible by IFN, transcription can be
studied as a variable at the same time as chromosomal
position. Lastly, by use of a promoter-trap enrichment
procedure, the proportion of stably transfected clones that
are targeted at the 6-16 locus is ~1/3, making targeted clones
easy to isolate (45).
Here we ®nd that cell lines carrying one or more ectopic
copies of 6-16 show only small variations in gene targeting
frequency. In the line with the best targeting frequency
(RAN10), however, we detected a strong preference for gene
targeting at a particular ectopic 6-16 allele. The extent of
this preference (34-fold) did not re¯ect a correspondingly
elevated targeting ef®ciency at the ectopic allele because the
absolute targeting frequency in RAN10 was only 3-fold higher
than in parental HT1080 cells. We therefore suggest that
different 6-16 alleles compete for interactions with the
targeting construct or for an essential recombination factor,
in a step that is not normally rate-limiting for gene targeting,




DNA cloning was carried out according to standard pro-
cedures. Plasmid p6-16neo contains the human 6-16 gene,
including the promotor and all ®ve exons, linked to a neo
selection marker. An 8.5 kb XhoI fragment carrying the
entire 6-16 gene and 2.3 kb of 5¢ sequence and a 2.9 kb
AccI±BamHI fragment containing the neo expression cassette
of pSV2neo (46) were cloned into the EcoRI and XbaI
sites, respectively, of pBSIIKS+ (Stratagene). The targeting
construct p6gpt has been previously described (47). It
contains a pBSIIKS+ backbone, 6.2 kb of 6-16 genomic
sequence (the 3¢ end of the genomic XhoI fragment, lacking
the 6-16 promotor) and a promotorless gpt marker within 6-16
intron 1. Both p6-16neo and p6gpt were built with HT1080-
isogenic DNA. pBSHPRTdSexhyg was constructed by
cloning the hygro cassette from pSV2hyg into SexA1-cut
pBSHPRT (47).
Cell culture and transfection
Human ®brosarcoma HT1080 cells (48), or their RAN
derivatives, were grown and electroporated as previously
described (45). `Diploid' cultures of HT0180 cells routinely
contain a proportion (~5%) of tetraploid cells even after
recloning. RAN10 and other tetraploid clones behave simi-
larly to `diploid' cultures during all cellular manipulations we
have used. DNA used for transfections was SalI-linearised p6-
16neo (8 mg), SalI-linearised p6gpt (8 mg), an 8 kb SmaI±SalI
fragment of p6gpt lacking the pBSIIKS+ backbone (4±6.5 mg)
or SalI-linearised pBSHPRTdSexhyg (8 mg). Drug selection
was started 48 h after electroporation and maintained
throughout. The RAN cell lines were selected initially in
400 mg/ml G418, reducing the concentration to 200 mg/ml
after ~4 weeks in culture. Selection for targeted RAN clones
was as follows. Cells (2.5 3 106/175 cm2 plate, 6 plates/
sample) were selected in 200 mg/ml G418, 2.5±10 mg/ml
mycophenolic acid (MPA), 100 mg/ml xanthine, in the
presence or absence of 100 IU/ml IFN (Wellferon, a mixture
of human type I IFNs; Glaxo-Wellcome). Between 14 and 19
days after electroporation the surviving colonies were either
stained with crystal violet and scored, or picked and ampli®ed
for further analyses. Selection for targeting in parental
HT1080 cells was as described for RAN cell lines but
omitting G418. Selection of pBSHPRTdSexhyg-transfected
cells was in hygromycin (100 mg/ml).
To test the effect of IFN or trichostatin A (TSA)
pretreatment on 6-16 gene targeting in RAN10, cells were
treated with or without 100 IU/ml IFN or 100 nM TSA, each in
the presence of 200 mg/ml G418, for a 72 h period (from 24 h
before electroporation until 48 h after electroporation) and
then selected in 200 mg/ml G418, 10 mg/ml MPA, 100 mg/ml
xanthine and 100 IU/ml IFN. Between 14 and 16 days after
electroporation the surviving colonies were picked and
expanded for further analyses. The effect of IFN pretreatment
on 6-16 gene targeting in wild-type HT1080 cells was
analysed likewise but omitting G418.
To test whether the MPA resistance of isolated cell
clones was IFN-dependent we split cells grown in
200 mg/ml G418, 10 mg/ml MPA, 100 mg/ml xanthine and
100 IU/ml IFN into duplicate samples (1.5 3 104 cells/well,
6-well plate) and selected in the presence or absence of IFN.
Differential growth was assessed after ~6 days culture by
visual inspection of both the colour of the medium and the cell
density.













Ploidy was assessed by analyses of propidium iodide stained
nuclei, as previously described (49).
Molecular analyses
PCR screening for 6-16 gene targeting was performed with
oligonucleotides O1 and O2 as previously described (45). This
reaction ampli®es a 1 kb fragment speci®c to cells targeted at
6-16 by using a primer from the 6-16 promotor and another
one from the gpt marker.
Southern blots for 6-16 analysis were done as previously
described, using genomic DNA from ampli®ed HT1080
clones and a 240 bp HaeIII±BamHI fragment from the 6-16
promotor as probe (45). Some blots were also hybridised
using SmaI-digested pBSIIKS+ as probe. DNA size markers
were a 1 kb ladder (M; Gibco BRL) or HindIII-digested
bacteriophage l DNA (l).
Northern analysis of 6-16 expression was essentially as
previously reported (45). Brie¯y, HT1080 cells were lysed
with guanidine thiocyanate and RNA was puri®ed by CsCl
centrifugation. The blots were probed with a 0.6 kb 6-16
cDNA.
RESULTS
The 6-16 gene targeting system
The 6-16 gene targeting construct (p6gpt) contains a
promoterless gpt gene incorporated into a promoterless
fragment of the 6-16 gene (Fig. 1A, a). When expressed, the
bacterial gpt gene confers resistance to the purine synthesis
inhibitor MPA on mammalian cells, if xanthine is also
included in the growth medium. HR between p6gpt and a
chromosomal 6-16 gene places the gpt gene under the control
of the IFN-responsive 6-16 promoter (Fig. 1A). Targeted
clones are therefore resistant to MPA and xanthine (MPA/X) if
IFN is also present. Molecular analyses (PCR and Southern
blots) are used to con®rm that IFN-dependent MPA/X-
resistant colonies are targeted. Most randomly integrated
p6gpt molecules fail to express gpt and their host cells die in
MPA/X, with or without IFN. A few random integration
events, however, activate gpt by chance and give rise to
colonies that grow in MPA/X. Unlike targeted clones, such
random integrants do not depend on IFN for their resistance
and are negative in molecular assays for targeted integration.
In this system, therefore, the proportion of selected clones that
are targeted (the relative targeting frequency, RTF) is
conveniently high (~1/3) (47), but the proportion of trans-
fected cells that are targeted (the absolute targeting frequency,
ATF) remains low (~1/106).
Generation and screening of cell lines with ectopic 6-16
alleles
To generate clones that carry one or more ectopic copies of the
6-16 gene integrated at random sites, a plasmid (p6-16neo,
Fig. 1B) carrying the 6-16 gene linked to a neo expression
cassette was electroporated into HT1080 cells and G418-
resistant clones were isolated. Eleven such cell lines (RAN1,
RAN2, etc.) were then transfected with the targeting construct
p6gpt. After electroporation, duplicate samples were selected
in G418/MPA/X, in the presence or absence of IFN, and
colony numbers were scored. Previous experiments (47)
showed that, for p6gpt-transfected HT1080 cells, approxi-
mately one-third of colonies selected in MPA/X/IFN are IFN-
dependent, the remainder being random integrants. It was
therefore expected that for HT1080 the number of colonies
selected with IFN present would be ~1.5-fold higher than the
number selected without, and that in any clones with elevated
targeting ef®ciencies this ratio would be higher. The observed
ratios (Supplementary Material) were variable and surpris-
ingly low, some even being <1. This probably indicates that
the plating ef®ciencies are impaired by the presence of IFN.
Nevertheless, two clones (RAN8 and RAN10) had elevated
ratios (averages of 1.75 and 2.42, respectively, n = 2), and
RAN10 was chosen for further analysis.
Absolute 6-16 gene targeting ef®ciency is elevated 3-fold
in RAN10
A more detailed comparison of gene targeting in HT1080 and
RAN10 was then made. Colonies selected in MPA/X/IFN
after transfection of p6gpt were tested for gene targeting by
PCR. Numbers of PCR-positive (T) and PCR-negative (R)
colonies were used to estimate the relative targeting fre-
quency. For most experiments these values were also used to
determine the random integration frequency (RIF) and ATF.
The data for each experiment are summarised in Table 1 and
mean values are compared in Tables 2±4. Signi®cant
increases, of 2.2- and 2.9-fold, respectively, in the RTF and
ATF for RAN10, compared to HT1080, were measured
(Table 2). A 2.1-fold decrease in RIF was noted, but was
outside the 95% con®dence limits. In separate experiments,
RAN10 and HT1080 formed hygromycin-resistant colonies
with similar ef®ciencies after transfection with a plasmid
(pBSHPRTdSexhyg-SalI) carrying a hygromycin resistance
cassette but no 6-16 gene sequences (not shown). The ~3-fold
increase in ATF therefore does not need to be adjusted upward
to compensate for any reduced transfectability of RAN10.
Figure 1. (A) The 6-16 gene targeting system. (a) Targeting construct p6gpt
with vector sequences removed. (b) The 6-16 gene. (c) The product of gene
targeting involving (a) and (b). (B) SalI-cut p6-16neo, used to generate ecto-
pic 6-16 alleles. DNA is represented as follows: black boxes, 6-16 gene
exons, numbered 1±5; white ellipse, IFN-responsive region of the 6-16 gene
promoter; thick lines, other 6-16 gene DNA; stippled boxes, multiple
cloning sites of pBSIIKS+; thin line, other pBluescript DNA; white boxes,
drug resistance cassettes; hatched box, SV40 early promoter; black bar,
target-speci®c probe in Southern analyses; short horizontal arrows, primers
used in PCR assay for targeting. A, Asp718; S, SalI.












RAN10 is tetraploid with two ectopic 6-16 alleles
Flow cytometry showed that RAN10 is tetraploid (data not
shown). In Southern blots, a probe spanning the 6-16 gene
promotor detected HindIII fragments of 11, 7.5 and 3.7 kb
(Fig. 2A). The 11 kb band was expected for the endogenous
6-16 alleles and was 4-fold more intense than either the 7.5
or 3.7 kb bands. The latter two bands represent distinct single
copy 6-16 alleles integrated at ectopic chromosomal sites, and
we will refer to these as the H7.5 and H3.7 alleles,
respectively. The 3.7 kb fragment is exactly as expected for
random integration of intact SalI-cut p6-16neo. The 7.5 kb
band, on the other hand, is likely to derive from a p6-16neo
molecule that has suffered loss of some 5¢ sequences,
including its HindIII site. The same 6-16 promoter probe
detected only single bands in blots of RAN10 genomic DNA
digested with BglI, PvuII, MfeI or SacI (not shown). The
maximum loss of 6-16 DNA from the 5¢ end of the H7.5 allele
is therefore 419 bp (the distance between the BglI and SalI
sites in p6-16neo). Both ectopic 6-16 alleles therefore retain
Table 2. Targeted and random integration frequencies: RAN10 versus HT1080
HT1080 Experiments RAN10 Experiments Fold difference P
ATF 0.72 6 0.22 2.1, 2.2, 2.3 2.06 6 0.49 4, 5.1, 5.2 +2.85 0.01
RIF 1.29 6 0.21 2.1, 2.2, 2.3 0.61 6 0.44 4, 5.1, 5.2 ±2.12 0.07
RTF 0.36 6 0.07 1, 2.1, 2.2, 2.3 0.80 6 0.13 4, 5.1, 5.2 +2.21 0.002
ATF, RIF and RTF are de®ned in Table 1. Means 6 standard errors were calculated for frequencies from the
indicated experiments in Table 1.
Table 4. Targeted and random integration frequencies: effect of IFN-pretreatment in RAN10
±IFN Experiments +IFN Experiments Fold difference P
ATF 2.27 6 0.47 5.1, 5.2 4.11 6 0.007 5.3, 5.4 +1.81 0.03
RIF 0.86 6 0.004 5.1, 5.2 0.46 6 0.23 5.3, 5.4 ±1.90 0.13
RTF 0.72 6 0.04 5.1, 5.2 0.90 6 0.05 5.3, 5.4 +1.25 0.052
See legend to Table 2.
Table 1. Summary of gene targeting experiments in HT1080 and RAN10
Exp. Cells DNA Seln N C T + R T R RTF RIF ATF
1 HT1080 8, p 2.5 27 10 17 0.37
2.1 HT1080 6.5, i 2.5 13.5 25 15 4 11 0.27 1.36 0.49
2.2 HT1080 6.5, i 10 16.2 29 17 7 10 0.41 1.05 0.74
2.3 HT1080 4, i 10 16.2 39 23 9 14 0.39 1.47 0.94
3.1 HT1080 8, p 10 12.5 16 15 8 7 0.53 0.6 0.68
3.2 HT1080 8, p 10 12.5 20 18 9 9 0.50 0.8 0.8
3.3 HT1080 8, p 10, I 15 14 13 10 3 0.77 0.22 0.72
3.4 HT1080 8, p 10, I 12.5 23 20 15 5 0.75 0.46 1.38
4 RAN10 4, i 10 15 26 18 17 1 0.94 0.10 1.64
5.1 RAN10 4, i 10 10 28 26 18 8 0.69 0.86 1.94
5.2 RAN10 4, i 10 15 52 28 21 7 0.75 0.87 2.6
5.3 RAN10 4, i 10, I 7.5 33 30 28 2 0.93 0.29 4.11
5.4 RAN10 4, i 10, I 15 71 23 20 3 0.87 0.62 4.12
6.1 RAN10 4, i 10 3 3 3 0 1.0
6.2 RAN10 4, i 10, T 5 4 4 0 1.0
Exp., experiments with the same whole number (e.g. 2.1, 2.2) were done in parallel, on the same day. DNA, DNA electroporated; numbers indicate mg used;
p, SalI-linearised p6gpt; i, puri®ed SmaI±SalI insert from p6gpt. Seln, selection conditions; numbers indicate concentration (mg/ml) of MPA; I, IFN-pretreated;
T, TSA-pretreated. N, number of cells electroporated (310±6). C, total number of colonies selected in MPA/X/IFN. T + R, number of colonies tested in PCR
assay for gene targeting. T, number of targeted integrants as detected by PCR. R, number of random integrants as detected by PCR. RTF, relative targeting
frequency = T/(T + R). RIF, random integration frequency (3106) = RC/N(T + R). ATF, absolute targeting frequency (3106) = TC/N(T + R).
Table 3. Targeted and random integration frequencies: effect of IFN-pretreatment in HT1080
±IFN Experiments +IFN Experiments Fold difference P
ATF 0.74 6 0.08 3.1, 3.2 1.05 6 0.47 3.3, 3.4 +1.41 0.46
RIF 0.70 6 0.14 3.1, 3.2 0.34 6 0.17 3.3, 3.4 ±2.07 0.15
RTF 0.52 6 0.02 3.1, 3.2 0.76 6 0.01 3.3, 3.4 +1.47 0.006
See legend to Table 2.












>1.8 kb of 6-16 sequences 5¢ of exon 1, far more than is
suf®cient for IFN-inducible transcription. The two ectopic
alleles also differ at their 3¢ ends: while they both retain the
neo-derived BglII site (Fig. 2B), the H7.5 allele has lost the
pBSIIKS+-derived NotI site (Fig. 2C). Finally, SmaI and
HindIII digests of RAN10, hybridised with either the 6-16
promotor probe or a pBSIIKS+ probe, showed that the two
chromosomal copies of p6-16neo are not arranged in tandem
and must have separate integration sites (not shown). Thus,
despite their differences (summarised in Fig. 2D), both ectopic
6-16 alleles appear to have intact 6-16 genes fully capable of
undergoing HR with p6gpt to generate MPAr clones.
Some 6-16 gene expression in RAN10 is IFN-
independent
In parental HT1080 cells the ~1 kb 6-16 transcript is barely
detectable prior to IFN treatment and is strongly up-regulated
by IFN (Fig. 3A) (50). In RAN10, however, two transcripts of
1 and 1.3 kb were detectable in the absence of IFN and both
were strongly up-regulated by IFN. A degree of inappropriate
`background' expression is typical for transgenes that lack
their usual sequence context and has been observed before for
6-16 (42). Other RAN clones tested had both transcripts and
similar but variable levels of uninduced expression (Fig. 3).
The presence of the 1.3 kb band in other RAN clones suggests
that some aspect of p6-16neo structure causes spurious
transcriptional initiation or termination, or aberrant RNA
splicing.
6-16 gene targeting in RAN10 is strongly biased toward
the H3.7 allele
Southern blots were used to con®rm that PCR-positive clones
were targeted at a 6-16 locus and to analyse the relative
frequency of gene targeting for the six 6-16 alleles present in
Figure 2. Structure of 6-16 alleles in RAN10. Genomic DNA was digested with HindIII (A), BglII (B) or BstZ17I and NotI (C), blotted and probed with the
target-speci®c probe shown in Figure 1. Genomic DNA was from HT1080, RAN10 or targeted RAN10 clones (RAN10T1, etc.) whose MPA resistance was
partially IFN-dependent. Size markers (M or l) are described in Materials and Methods and sizes (kb) of arrowed markers are indicated. (D) Schematic repre-
sentation of the endogenous (a) and ectopic copies (b and c) of 6-16 in RAN10. DNA is represented as in Figure 1. Relevant sites are shown for Asp718 (A),
BglI (Bi), BglII (Bii), BstZ17I (Bs), HindIII (H), PvuII (Pv), MfeI (M), NotI (N) and SacI (S).












RAN10 (Fig. 4). Gene targeting with p6gpt increases the size
of 6-16 HindIII fragments by 1.8 kb, i.e. from 11 to 12.8 kb for
the endogenous alleles (Fig. 4, lanes 2 and 3) and, for the
ectopic alleles, from 3.7 to 5.5 kb (Fig. 4, lane 4) or from 7.5 to
9.3 kb (Fig. 4, lane 5). Remarkably, PCR-positive RAN10
subclones showed a near complete bias for targeting at the
H3.7 allele: of the 56 PCR-positive clones generated in
experiments 4, 5.1 and 5.2 (Table 1), 48 were clearly targeted
at the H3.7 allele, and none was targeted at an endogenous
6-16 allele (Fig. 4). Furthermore, six of the remaining eight
clones appeared to have undergone unusual targeting events
involving the H3.7 allele. Thus three clones (see, for
example, Fig. 4, lane 10) had gained a 5.5 kb HindIII
band without losing the 3.7 kb band [these probably
represent `pick-up' events (51,52)] and another three clones
(see, for example, Fig. 4, lanes 8, 9 and 11) had lost the 3.7 kb
band but had gained a band that was not the predicted size of
5.5 kb. One of the latter clones (Fig. 4, lane 11) had also
undergone an unpredicted change at the H7.5 allele. The
remaining two clones had the same HindIII pattern as RAN10
(lane 2 in Fig. 4), even though they were targeted at 6-16
according to the PCR screening (repeated for con®rmation). In
summary, 96% (54/56) of clones had undergone a gene
targeting or gene targeting-related event involving the H3.7
allele. Of equal note to this bias was the apparent lowering of
the ATF for the endogenous alleles to an undetectable level.
Thus, for experiments 4, 5.1 and 5.2 combined, the expected
number of clones with targeted endogenous 6-16 alleles is 20
[using the ATF for HT1080 of 0.72 6 0.22 3 10±6 and the
formula ATF 3 N(T + R)/C], but no such clones were
detected.
Clones with targeted H3.7 alleles are only partially
IFN-dependent
As described (45), targeted modi®cation of an endogenous
6-16 allele with p6gpt generates HT1080 cells whose resist-
ance to MPA is IFN-dependent. In initial tests for such IFN
dependence, none of the 56 PCR-positive clones from
experiments 4, 5.1 and 5.2 was found to be IFN-dependent.
In more detailed analyses, however, involving selection at
lower cell densities (Materials and Methods), it was clear that
most clones (37/39) grew less well in the absence of IFN than
in its presence, the remaining two being completely IFN-
independent (Fig. 3B). We conclude from this that the H3.7
allele is at least partly responsible for the IFN-independent
6-16 transcription detected in RAN10 (Fig. 3A) and that this is
suf®cient to confer, after targeting with p6gpt, partial resist-
ance to MPA. The two clones whose growth was not improved
by IFN corresponded to clones that had atypical Southern
patterns (Fig. 4, lanes 2 and 8), suggesting that they have
undergone an unusual event in which a 6-16 allele has become
linked to a constitutively active promoter.
An improved ability of targeted RAN clones to grow
without IFN may help to explain some of the surprisingly low
+IFN:±IFN ratios seen during the screening of RAN clones.
Targeting bias in RAN10 persists when all 6-16 alleles
are transcribed
It was possible that preferential targeting at the H3.7 allele in
RAN10 was a consequence of the appreciable transcription of
this allele seen in the absence of IFN. To test this possibility
we performed a 6-16 gene targeting experiment in RAN10
Figure 3. Evidence for constitutive 6-16 transcription of the H3.7 allele in
RAN cell lines. (A) Northern blot of RNA isolated from cell lines grown
with or without IFN treatment, as indicated. (B) Tests for IFN dependence
of resistance to MPA. Cells were seeded at low density and grown in
selective medium with or without IFN (Materials and Methods). Results for
RAN10 and ®ve p6gpt-transfected, MPAr derivatives are shown. RAN10T4
was not targeted at a 6-16 allele, as judged by PCR and Southern analyses.
The remaining clones were targeted at an endogenous allele (RAN10T4I
and RAN10T46I) or at the H3.7 allele (RAN10T31 and RAN10T36), as
judged by PCR and Southern analyses.
Figure 4. Southern blot analyses of HindIII-digested genomic DNA from
HT1080, RAN10 and nine representative p6gpt-transfected RAN10 deriva-
tives. In total, 108 MPAr, PCR-positive clones, derived from experiments
4±6 (Table 1), were analysed in this way and each generated one of the 10
representative hybridisation patterns shown in lanes 2±11, as indicated
below the autoradiograph. The probe was as shown in Figure 1A.












cells that had been pretreated with IFN (Table 1, experiments
5.3 and 5.4). In this case, all four endogenous 6-16 alleles (and
possibly the H7.5 allele), as well as the H3.7 allele, are
actively transcribed at the time of transfection with p6gpt.
Thus, if the targeting bias in RAN10 observed without IFN
pretreatment is due to differential transcription, we would
expect the bias to disappear in pretreated cells. After selection
in G418/IFN/MPA/X we recovered 53 clones, 48 of which
were targeted at 6-16 according to the PCR screening.
Southern blot analyses of the 48 PCR-positive clones showed
that 36/48 (43/48 if pick-up events are included) were targeted
at the H3.7 allele, 2/48 at the H7.5 allele (both of them pick-up
events; Fig. 4, lane 5), 2/48 at an endogenous allele (Fig. 4,
lanes 3 and 6) and 1/48 at both the H7.5 allele and an
endogenous allele (Fig. 4, lane 7). Thus, IFN pretreatment had
little effect on the bias towards targeting of the H3.7 allele and
we conclude that preferential targeting at H3.7 is not primarily
the result of IFN-independent transcription of this allele. In
both HT1080 and RAN10 cells we detected small increases
(1.4- and 1.8-fold, respectively) in the ATF as a result of IFN
pretreatment, although only the latter was signi®cant (Tables 3
and 4). While suggesting that our IFN pretreatment was
effective, these small or insigni®cant increases contrast with
the 3- to 20-fold stimulation reported for another targeting
system (34).
Although we did detect three clones with a targeted
endogenous 6-16 allele, this was again fewer than the eight
clones predicted [using the ATF for HT1080 of 0.72 6 0.22 3
10±6 and the formula ATF 3 N(T + R)/C].
The 48 PCR-positive clones were tested for the IFN
dependence of their resistance to MPA. Again, the majority
(46/48) showed a partial dependence on IFN. The remaining
two clones were fully IFN-dependent (Fig. 3B) and corres-
ponded to those that had been targeted at an endogenous 6-16
allele (lanes 3 and 6 in Fig. 4). The lower than expected
number of clones targeted at an endogenous 6-16 allele
therefore does not appear to be the result of any impaired
transcription of endogenous 6-16 alleles in RAN10.
TSA treatment does not alter the gene targeting bias in
RAN10
To test whether the 6-16 gene targeting bias in RAN10 was
determined by allelic differences in histone acetylation, we
carried out experiments in cells pretreated with TSA, a known
inhibitor of histone deacetylation. Pilot experiments were
conducted to titrate TSA in HT1080 cells and concentrations
were chosen that allowed cell growth and normal survival
after electroporation, even though they caused morphological
changes. We electroporated 6-16gpt into RAN10 cells
pretreated with or without TSA and selected in G418/IFN/
MPA/X (Table 1, experiment 6). Five colonies were recovered
from TSA-treated cells, four of which were expanded and
analysed by Southern blot for 6-16 gene targeting (Fig. 4). All
four of them were targeted at the H3.7 allele.
DISCUSSION
The key observation in this study is the pronounced preference
for gene targeting to one particular 6-16 allele (H3.7) in a cell
line (RAN10) that contains ®ve other 6-16 alleles. Thus, of
108 candidate clones analysed (Fig. 4), 101 involved the H3.7
allele and only three involved an endogenous 6-16 allele.
Targeting of the 6-16 gene in RAN10 is therefore 34-fold
more likely to occur at the H3.7 allele than at any of the
endogenous 6-16 alleles.
The cloned 6-16 DNA used to make the targeting construct
and the two ectopic target loci was derived from the HT1080
cell line used for these experiments. The H3.7 allele is
therefore identical in its nucleotide sequence to three of the
®ve other 6-16 alleles in RAN10; the remaining two
(endogenous) copies may or may not be identical depending
on whether polymorphisms exist at this locus in HT1080.
Some feature of the chromatin or DNA sequence context of
the H3.7 allele must therefore be responsible for its
preferability. At present we do not know what this feature
is. A preliminary experiment with TSA suggests that the bias
does not depend on histone deacetylation, but more detailed
analyses of this kind would be of interest. Characterisation of
the H3.7 integration site will also be informative as this may
reveal genomic sequences (e.g. tandem or inverted repeats) as
candidates responsible for the position effect. Such sequences
might be naturally occurring or result from rearrangements
generated during random integration of the H3.7 allele.
Another possibility is that the SV40 ori/enhancer in the neo
cassette close to the preferred target gene is responsible,
because this may have been lost during integration of the other
ectopic allele (H7.5). The SV40 ori/enhancer has been
detected as a site of chromatin remodeling in SV40 (53) and
Drosophila (54) chromosomes and has been associated with
genomic instability in mouse cell lines (55). If the SV40
enhancer is responsible it seems unlikely that its effect can be
explained simply in terms of its potential to stimulate
transcription because we were able to show that the bias was
not altered when transcription of all six loci was induced by
IFN. While the SV40 ori/enhancer is not a normal constituent
of the mammalian genome, any sequence capable of in¯uenc-
ing gene targeting is of interest and could provide clues as to
the nature of analogous mammalian genomic sequences.
Regardless of the underlying cause, our results clearly show
that sequence and/or chromosome context can have a
profound in¯uence on gene targeting. Given the known
existence of recombination hotspots in a variety of recombin-
ation systems, and that chromosomal context is well known to
have important in¯uences on gene expression, an effect of
chromosomal context on gene targeting is not unexpected.
Nevertheless, unequivocal data in support of a chromosomal
position effect on gene targeting in mammalian cells have not
previously been reported. Our data not only provide such
support but also, as outlined below, suggest ways in which the
effect might be acting.
The effect of chromatin and/or sequence context on gene
targeting cannot simply be to stimulate the overall ef®ciency
of gene targeting at the H3.7 allele. If that were true, the 34-
fold preference for targeting at the H3.7 allele would be
mirrored by a similar increase in the ATF for RAN10. In fact,
the ATF in RAN10 was only 3-fold higher than in HT1080.
Any model to explain preferential targeting of the H3.7 allele
must not only account for this relatively mild stimulation of
the ATF in RAN10, but also for the signi®cantly lower than
expected frequency of targeting events involving 6-16 alleles
other than H3.7 in RAN10. In Figure 5 we outline three
distinct models that satisfy these requirements. Variations on












these models can be envisaged and further work will be
required to determine which, if any, is correct. All three
models depend on an enhanced ability of the H3.7 allele,
compared to other 6-16 sequences, to interact with a key,
sometimes limiting, component in the gene targeting pathway.
In the ®rst model (Fig. 5A), the H3.7 allele interacts
preferentially with the targeting construct during the initial
homology search stage of gene targeting. Several studies
(39,41,56,57) indicate that the homology search is not rate-
limiting for gene targeting, and this would help to explain the
limited increase in ATF in RAN10. To explain the much lower
than expected frequency of targeting events involving 6-16
alleles other than H3.7, it is suggested that the targeting
construct is limiting so that its preferential recruitment to the
H3.7 allele makes it unavailable for targeting at other 6-16
alleles. We do not know how many DNA molecules reach the
nucleus in our electroporation protocol, but it is known that
electroporation can be particularly ef®cient in generating
transfectants with single copy integrations (58), and it is
therefore conceivable that intact targeting constructs are
limiting. Furthermore, of those targeting constructs that do
reach the nucleus intact, the majority are likely to be
channeled into non-homologous end-joining pathways, lead-
ing to integration at random sites, and are therefore unavail-
able for gene targeting. Finally, it is possible that the H3.7
allele is capable of interacting with multiple targeting
constructs at once, rather than just one, further limiting the
availability of targeting constructs at other 6-16 loci.
Nevertheless, the model predicts that, for conditions where
targeting construct availability is not limited (e.g. high
concentrations of targeting construct), preferential targeting
at H3.7 will no longer be observed.
In the second model (Fig. 5B), all 6-16 alleles interact with
the targeting construct with similar ef®ciencies during the
homology search, but the H3.7 allele preferentially recruits a
factor that is essential for a later step in the gene targeting
pathway. Preferential recruitment of this factor to the H3.7
allele does not greatly stimulate the targeting ef®ciency,
suggesting that recruitment of the factor is not normally rate-
limiting for gene targeting. Preferential recruitment to the
H3.7 allele does, however, reduce the concentration of factor
available for recruitment to other 6-16 alleles, to the extent
that recruitment becomes rate-limiting for gene targeting at
these alleles. In this model, preferential targeting to the H3.7
allele is predicted to be independent of the concentration of
targeting construct. Another testable prediction is that target-
ing events involving the H3.7 allele would suppress HR
pathways that do not involve 6-16 sequences.
In the third model (Fig. 5C) the H3.7 allele competes with
the targeting construct for interaction with other 6-16 alleles.
Thus the H3.7 allele either prevents the targeting construct
from interacting with other 6-16 alleles or disrupts any
established interaction. This effect is non-reciprocal in the
sense that access to the H3.7 allele by the targeting construct is
relatively unaffected by the other 6-16 alleles. The model is
based on a study (59) in which repair by HR of a damaged
repetitive LINE element in mouse cells used other genomic
LINE elements as recombination partners. Choice of the donor
LINE elements appeared to depend more on its availability
than on its degree of homology with the damaged element. We
can thus imagine that, on the rare occasions when a 6-16 allele
is competent to undergo HR, the H3.7 allele is in a
chromosomal context that makes it more available as an HR
partner than either the targeting construct or the other 6-16
alleles (Fig. 5C, a). Conversely, when the H3.7 is competent to
undergo HR, other 6-16 alleles are not so favourably
positioned to compete with the targeting construct (Fig. 5C,
b). This model does not necessarily require any component to
be present in limiting amounts and could accommodate an
independence of preferential targeting on targeting construct
concentration. The model also predicts that HR pathways in
RAN10 that do not involve 6-16 DNA will not be affected by
targeting at the H3.7 allele.
The chromosomal position effect we have observed has its
main in¯uence on target locus preference with a relatively
small but signi®cant effect on the overall ef®ciency of gene
targeting. It might therefore appear that this effect is of minor
importance in typical gene targeting situations, where there
are usually only two target loci at equivalent chromosomal
locations on homologous chromosomes, and is therefore
unable to explain wide variations in gene targeting ef®ciencies
for different target genes. It is interesting to consider the
possibility, however, that non-homologous sequences also
compete with the target loci during the initial genome scan. If
this were true, the chromosomal position effect we have
observed might have an important effect on the choice
Figure 5. Three models to explain preferential targeting to H3.7 without
increased ATF. Regions of homology are shown as white boxes. Hatched
and stippled regions represent chromosomal ¯anking sequences at H3.7 and
other 6-16 alleles, respectively. RLS, rate-limiting step. (A) Competition
between H3.7 and other alleles for interaction with limiting amounts of
targeting construct. (B) Competition between H3.7 and other 6-16 alleles
for recruitment of a limiting factor (ellipse) required for HR. (C) Interallelic
interference. (a) The H3.7 allele physically interacts with endogenous 6-16
alleles, preventing access by the targeting construct. (b) Endogenous 6-16
alleles do not impair access to the H3.7 allele by the targeting construct.
See text for further details.












between random and targeted integration pathways. This may
explain the fact that our estimates of RIF for the 6-16 gene
targeting construct, but not for a simple expression cassette,
were lower in RAN10 than in HT1080 cells. If this is correct,
differences between the different target loci in their ability to
compete with the rest of the genome for interaction with the
targeting construct might account for at least some of the
reported variation in gene targeting ef®ciencies.
In conclusion, our data provide clear evidence for a strong
in¯uence of chromosomal position on gene targeting in human
cells. This in¯uence appears to be on a step that is not rate-
determining, such as the homology search, or on a later step
for which an essential factor is limiting. The position effect
thus has its main in¯uence on the choice between identical
targets at different loci in the same cell, with relatively little
effect on the overall frequency of gene targeting.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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